Polycythemia Vera
📧 Sign up to get email alerts when something new happens for Polycythemia Vera.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study
A multicenter study is evaluating real-world data on ropeginterferon alfa-2b for polycythemia vera, with enrollment not yet started.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes [NA]
A clinical trial is ongoing to characterize monocytes in myeloproliferative neoplasms, with recruitment currently in progress.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Blood Viscosity in Polycythemia Patients
A clinical trial update indicating a study on blood viscosity in primary and secondary polycythemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis [Phase 1]
Phase 1 clinical trial evaluating the combination of ruxolitinib and abemaciclib for myelofibrosis (including myelofibrosis associated with …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera
This ClinicalTrials.gov study sponsored by Novartis seeks to identify predictive factors for thromboembolic events in high-risk polycythemia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: A Study of GLB-001 in Patients With Myeloid Malignancies [Phase 1]
A Phase 1 clinical trial evaluating GLB-001 in patients with myeloid malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV [Phase 3]
This entry reports on a Phase 3 study evaluating P1101 in adults with polycythemia vera. The trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera [Phase 3]
Phase 3 clinical trial update for rusfertide in patients with polycythemia vera; the study is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU [Phase 2]
Phase 2 study evaluating the efficacy and safety of P1101 in Chinese patients with polycythemia vera who are intolerant or resistant to hydr…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera [Phase 4]
This clinical trial update reports on a Phase 4 study of Ropeginterferon alfa-2b (P1101) for polycythemia vera, focusing on efficacy and saf…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV) [Phase 1]
Phase 1 clinical trial update for BEBT-507 Injection in Polycythemia vera; the study is currently NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History [NA]
This clinical trial update describes a study assessing the prevalence of germline gene mutations in patients with myeloproliferative neoplas…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera [Phase 1]
A Phase 1 study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of 9MW3011 in patients with polycyth…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms
This clinical trial investigates how extracellular vesicle–driven senescence contributes to myeloproliferative neoplasms, including essentia…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Efficacy and Safety of Peginterferon in ET and PV. [NA]
This document reports a currently recruiting clinical trial evaluating the efficacy and safety of peginterferon in essential thrombocythemia…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
A recruiting clinical trial is evaluating ruxolitinib in patients with myelofibrosis, including primary myelofibrosis and myelofibrosis seco…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera [Phase 3]
A Phase 3 trial comparing ruxolitinib to hydroxycarbamide or interferon as first-line therapy for high-risk polycythemia vera, currently rec…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients [Phase 3]
An extension study of P1101 is planned after completion of Phase 2 in polycythemia vera or Phase 3 in essential thrombocythemia; the trial i…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Aquagenic Pruritus in Myeloproliferative Neoplasms
A completed clinical trial investigating aquagenic pruritus in patients with myeloproliferative neoplasms.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Myeloproliferative Neoplasms (MPNs) Patient Registry
An update on the Myeloproliferative Neoplasms (MPNs) Patient Registry sponsored by University Health Network in Toronto, currently recruitin…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Myeloproliferative Neoplastic Diseases Observatory From Brest
A Brest-based clinical trial observatory update for myeloproliferative neoplasms, enrolling patients with polycythemia vera, essential throm…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition [Phase 1]
A Phase 1 clinical trial at Fox Chase Cancer Center tests the combination of pacritinib and talazoparib in myeloproliferative neoplasms unre…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
A completed NIH-backed clinical trial examining molecular changes and biomarkers in chronic myeloproliferative disorders including polycythe…
-
CLINICAL_TRIALS research · 2016-06-22Clinical Trial Update: Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features
Clinical trial update examining how often iron deficiency occurs in polycythemia vera and its relationship to disease features.
-
CLINICAL_TRIALS research · 2015-10-01Clinical Trial Update: Natural Killer Cells and Polycythemia Vera (Vaquez's Disease)
An update on a clinical trial investigating natural killer cells in patients with polycythemia vera (Vaquez's disease).